NEAUA 78th Annual Meeting, September 24 - 26, 2009, Renaissance Hotel, Washington, DC
 
NEW ENGLAND SECTION - AUA
78th ANNUAL MEETING
September 24 – 26, 2009
Renaissance Hotel
Washington, DC
 
THURSDAY, SEPTEMBER 24, 2009
7:00 am - 8:30 am AUA INSTRUCTIONAL COURSE
Meeting Rooms 12-14
Urology Practice Presentation: Governance, Recruitment and Physician Phase-out
Steven M. Schlossberg, MD
7:00 am - 9:00 am AUA INSTRUCTIONAL COURSE
Grand Ballroom North
Prostate Cancer Multidisciplinary Management in the Baby Boom Generation
Judd W. Moul, MD
9:00 am - 9:15 am INTRODUCTION & WELCOME
Grand Ballroom North

Kevin R. Loughlin, MD, President
New England Section of the American Urological Association

Datta Wagle, MD, President-Elect
American Urological Association

9:15 am - 10:05 am SCIENTIFIC SESSION I: PROSTATE CANCER
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Peter C. Albertsen
Martin G. Sanda
9:15 am 1. Choosing a Prostate Cancer Treatment: Can Integrated Decision Aids Improve Patient Decision Making?
John D. Seigne, MB, Telisa Stewart, BA, Telisa Stewart, BA, Kate Clay, MA, BSN, Stephen Kearing, MS, John Heaney, MB
Dartmouth Hitchcock Medical Center, Lebanon, NH
9:25 am 2. PSA Density, PSA Velocity and Family History of Prostate Cancer are Predictors of Progression in Patients with Low Risk Prostate Cancer on Active Surveillance Protocol Using a 20-Core Saturation Biopsy Technique
Ignacio F. San Francisco, MD1, Glenn Bubley, MD2, Marc B. Garnick, MD2, William C. DeWolf, MD2
1Beth Israel Deaconess Medical Center and Pontificia Universidad Catolica de Chile, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA
9:35 am 3.+ Multiple Urology Practice Cohort Validation of the Prostate Cancer Prevention Trial (PCPT) Calculator for Predicting Prostate Cancer Detection
Stephen J. Eyre, MD1, Donna P. Ankerst, PhD2, John T. Wei, MD3, Prakash V. Nair, MS3, Meredith Regan, Sc.D5,7, Geri Bueti, BS1, Jeff Tang, BS1, Mark Rubin, MD6, Michael Kearney, MD1, Ian M. Thompson, MD7, Martin G. Sanda, MD1,7
1Division of Urology, Beth Israel Deaconess Medical Center, Boston, MA, 2Department of Mathematics, Technical University; Munich, Germany, 3Departments of Urology, Epidemiology and Biostatistics, UTHSCSA, San Antonio, TX, 4Department of Urology, University of Michigan, Ann Arbor, MI, 5Depertment of Biostatistics and Camputational Biology, Dana Farber Cancer Institute, Boston, MA, 6Department of Pathology and Laboratory Medicine, Weill-Cornell Medical College, New York, NY, 7Harvard Medical School, Boston, MA
9:45 am 4. Use of New High Spatial Resolution 3T MRI Technique to Identify Prostate Cancer Missed on Routine Biopsy
David F. Yao, MD, William C. DeWolf, MD, Martin G. Sanda, MD, B. Nicholas Bloch, MD, Elizabeth M. Genega, MD, Alexander M. Berry, MD, Long Ngo, MD, Neil M. Rofsky, MD
Beth Israel Deaconess Medical Center, Boston, MA
9:55 am 5. Is Second Opinion Pathologic Confirmation Necessary for Patients With Prostate Cancer?
Beth A. Drzewiecki, MD, Brook Harnisch, MD, Aaron Weinberg, BS, Richard K. Babayan, MD, David S. Wang, MD
Boston Medical Center, Boston, MA
10:05 am - 11:15 am SCIENTIFIC SESSION II: GENERAL UROLOGY / BPH
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Lori B. Lerner
Shahin Tabatabaei
10:05 am 6. First Long Acting Testosterone Undecanoate Injection to Treat Male Hypogonadism: 21 Month Safety and Efficacy Outcomes
Abraham Morgentaler, MD1 , Joel M. Kaufman, MD2 , Ridwan Shabsigh, MD3, Martin M. Miner, MD4, Ronald S. Swerdloff, MD5, Christina Wang, MD5 , Adrian S. Dobs, MD, MHS6
1Harvard Medical School, Boston, MA, 2University of Colorado School of Medicine, Denver, CO, 3Maimonides Medical Center and Columbia University, New York, NY, 4The Warren Alpert Medical School of Brown University, Providence, RI, 5David Geffen School of Medicine at UCLA, Los Angeles, CA, 6Johns Hopkins University School of Medicine, Baltimore, MD
10:15 am 7. Cost Analysis of Surgical Approaches for Bladder Outlet Obstruction: Laser Versus Loop
Samuel H. Eaton, MD1, Lori B. Lerner, MD2
1Boston Medical Center, Boston, MA, 2VA Boston Healthcare System, Boston, MA
10:25 am 8. Does the National Surgical Quality Improvement Program Identify Valid
Urinary Tract Infections Postoperatively?
Samantha J. Ganick, MD1, Vikrant Uberoi, MD1, Lori Lerner, MD2 1Boston Medical Center, Boston, MA, 2Veterens Administration Medical Center, Boston, MA
10:35 am 9. Photo-Selective KTP Laser Vaporization of Large (Greater than 80 CC), Obstructive Prosatate: Four Years Experience
Sarah P. Psutka, MD, Mohammad M. Siddiqui, MD, Shahin Tabatabaei, MD
Massachusetts General Hospital, Boston, MA
10:45 am 10. Determination of Risk Factors for Surgical Complications in the Pediatric Population: Analysis of 98 Peri-operative Parameters
Aaron C. Weinberg, BS, Bradford Tinloy, BS, Mordechai D. Raskas, BA, Frank J. Penna, MD, Lin Huang, PhD, Drew A. Freilich, MD, Alan B. Retik, MD, Hiep T. Nguyen, MD
Children's Hospital Boston, Boston, MA
10:55 am 11. Bipolar Electrosurgical Enucleation of the Prostate: Technical Progress And Early Clinical Experience of a Novel Technique
Jessica Mandeville, MD, Robert A. Roth, MD, Arthur Mourtzinos, MD
Lahey Clinic Medical Center, Burlington, MA
11:05 am 12. Management of Urethral Strictures Following Radiation Therapy
Alex J. Vanni, MD, Spencer Kozinn, MD, Leonard N. Zinman, MD, Jill C. Buckley, MD
Lahey Clinic, Burlington, MA
11:15 am - 12:00 pm Your Urologic Advocacy Efforts 2009-2010
Moderator:
Kevin Loughlin, MD
NEAUA President

Panel:
Art Tarantino, MD
NEAUA Member

Priscilla Chatman, JD
Director of Government Relations and Advocacy

Brian S. Bailey
UROPAC Staff Member

Steven M. Schlossberg, MD
Chair of the Health Policy Council
12:15 pm - 12:45 pm Guest Speaker:
Vicki Hart
Principal, Hart Health Strategies, AUA External Lobbyist
12:45 pm - 1:30 pm ADVOCACY TRAINING LUNCH
2:00 pm - 5:00 pm CAPITOL HILL VISITS
5:30 pm - 7:00 pm WELCOME RECEPTION
Grand Ballroom South/Central
FRIDAY, SEPTEMBER 25, 2009
6:30 am - 8:00 am Breakfast Symposium
Meeting Rooms 8 & 9
Understanding Referring PCP Needs to Improve the Overall Patient Experience
Supported by Procter & Gamble Healthcare
Description:
Who is the referring PCP? What do they want from their Urologists? Research answers how Urologists can improve relationships with referring PCPs. Implementing these insights will help enhance your Urological services to improve patient satisfaction and patient care goals through PCP referrals and transition of care.
7:30 am - 11:20 am Exhibit Hall
Grand Ballroom South/Central
3:40 am - 4:10 pm Exhibit Hall
Grand Ballroom South/Central
7:30 am - 8:30 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Grand Ballroom South/Central
8:00 am - 9:10 am SCIENTIFIC SESSION III: PROSTATE LAPAROSCOPY
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Douglas M. Dahl
Louis R. Kavoussi
8:00 am 13. Prostate Cancer Biochemical Recurrence Rates After Robot-Assisted Laparoscopic Radical Prostatectomy
Serge Ginzburg, MD1, Ilene Staff, PhD2, Joseph Tortora, BA2, Alison Champagne, BS2, Steven J. Shichman, MD2, Stuart S. Kesler, MD2, Vincent P. Laudone, MD3, Joseph R. Wagner, MD2
1University of Connecticut, Farmington, CT, 2Hartford Hospital, Hartford, CT, 3Memorial Sloan-Kettering Cancer Center, New York, NY
8:10 am 14. Functional Outcomes After Robot-Assisted Laparoscopic Radical Prostatectomy
Serge Ginzburg, MD1, Ilene Staff, PhD2, Joseph Tortora, BA2, Alison Champagne, BS2, Steven J. Shichman, MD2, Stuart S. Kesler, MD2, Vincent P. Laudone, MD3, Joseph R. Wagner, MD2
1University of Connecticut, Farmington, CT, 2Hartford Hospital, Hartford, CT, 3Memorial Sloan-Kettering Cancer Center, New York, NY
8:20 am 15.+ Learning Curve in Robotic-Assisted Laparoscopic Prostatectomy: When Does It End?
David W. McDermott, Jr., MD, Aaron Weinberg, BS, Jim C. Hu, MD, MPH
Brigham and Women's Hospital, Boston, MA
8:30 am 16. Variations in Utilization Patterns of Pelvic Lymph Node Dissection During Open And Minimally Invasive Radical Prostatectomy Exist Independent Of Pathologic Grade And Stage
Sandip M. Prasad, MD, M. Phil, Michaella M. Prasad, MD, Jim C. Hu, MD, MPH
Harvard-Longwood Program in Urology, Boston, MA
8:40 am 17. Predictors of Post-Prostatectomy Incontinence: A Multivariate Analysis
Brian F. Chapin, MD, Adam S. Feldman, MD, Sarah D. Psutka, Douglas M. Dahl, MD
Massachusetts General Hospital, Boston, MA
8:50 am 18. Skeletonization of DVC Followed By Ligature with A Single Stitch During RARP: Its Role In Early Continence Recovery
Sergey Kravchick, MD1, Stephen Williams, MD1, Ronit Peled, PhD2, Marcos Paulo Freire, MD1, Lei Yin, MD1, Aaron C. Weinberg, Ph1, Jim Hu, MD1
1Brigham and Women's Hospital, Boston, MA, 2Health Systems Management Research, Talmey Yaffe, Israel
9:00 am 19. Endoscopic stapler for the deep venous complex (DVC) control during Robotic Assisted Laparoscopic Radical Prostatectomy (RALRP) (146)
Sergey Kravchick, MD1, Stephen Williams, MD1, Ronit Peled, PhD2, Marcos Paulo Freire, MD1, Lei Yin, MD1, Aaron C. Weinberg, Ph1, Jim Hu, MD1
1Brigham and Women's Hospital, Boston, MA, 2Health Systems Management Research, Talmey Yaffe, Israel
9:10 am - 9:40 am POINT COUNTERPOINT - Radical Prostatectomy
Grand Ballroom North
Moderator: Kevin R. Loughlin

Francis McGovern, MD, Boston, MA
Anything A Robot Can Do, A Scalpel Can Do Better

Richard Babayan, MD, Boston MA
Wake Up And Smell the Coffee, The Robot Is The Way To Go
9:40 am - 10:50 am CONCURRENT SCIENTIFIC SESSION IV: UPPER TRACT AND BLADDER LAPAROSCOPY
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Alireza Moinzadeh
Andrew A. Wagner
9:40 am 20. Laparoscopic Exploration for the Detection and Treatment of Early Complications from Laparoscopic Urologic Surgery
Matthew Wszolek, MD, Alireza Moinzadeh, MD, Ingolf Tuerk, MD, Andrea Sorcini, MD
Lahey Clinic, Burlington, MA
9:50 am 21. Temporary Segmental Renal Artery Occlusion Using a Novel Reverse Phase Polymer for Robotic Partial Nephrectomy in a Swine Model
Sara Lenherr, MD1, Ali Moinzadeh, MD1, Sebastian Flacke, MD, PhD1, Kathryn Lyall, MS2, John Merhige, M.E.M.3, Curtis W. Bakal, MD, MPH1, Jean-Marie Vogel, BA3, John A. Libertino, M.E.M.1, Peter N. Madras, MD3
1Lahey Clinic Medical Center, Burlington, MA, 2Intuitive Surgical, Inc, Sunnyvale, CA, 3Pluromed Inc., Woburn, MA
10:00 am 22. Robotic Versus Open Ureteral Reimplantation for Distal Ureter Benign Stricture Disease
Spencer I. Kozinn, MD, Jessica Mandeville, MD, Karim Hamawy, MD, Andrea Sorcini, MD, David Canes, MD, John A. Libertino, MD, Ali Moinzadeh, MD
Lahey Clinic Medical Center, Burlington, MA
10:10 am 23. Intraoperative Fluorescent Molecular Imaging of Vascular Perfusion in Minimally-Invasive Repair of Ureteropelvic Junction Obstruction: an Evaluation of Pyelo-ureteral Anastomotic Viability Using Indocyanine Green Fluorescence in a Pig Model
Frank J. Penna, MD, Andres D. Silva, MD, Brian J. Minnillo, MD, Samantha Ganick, MD, Rian J. Dickstein, MD, Hiep T. Nguyen, MD
Children's Hospital Boston, Boston, MA
10:20 am 24. A Prospective Randomized Controlled Trial Assessing the Use of Aerosolized Intraperitoneal Bupivacaine in Reducing Postoperative Pain in Children Undergoing Laparoscopic Surgery: Preliminary Results
Brian J. Minnillo, MD, Frank J. Penna, MD, Constance S. Houck, MD, Petra M. Meier, MD, Andres D. Silva, MD, Drew A. Freilich, MD, Hiep T. Nguyen, MD
Children's Hospital Boston, Boston, MA
10:30 am 25. Robotic-Assisted Laparoscopic and Laparoscopic Partial Nephrectomy; A Comparison of a Single-Surgeon's Experience
Anne M. Suskind, MD1, Ryan C. Jackson2, Ilene Staff2, Steven J. Shichman, MD2
1University of Connecticut, Farmington, CT, 2Hartford Hospital, Hartford, CT
10:40 am 26. Outcomes Assessment Of Laparoscopic Partial Nephrectomy: Is There An Increased Rate Of Postoperative Bleeding Events?
William V. Shappley, III, MD1, Sandip M. Prasad, MD1, Michaella M. Prasad, MD1, Jodi Mechaber, NP2, Anna Dowdle, BS2, Andrew A. Wagner, MD2
1Brigham & Women's Hospital, Boston, MA, 2Beth Israel Deaconess Medical Center, Boston, MA
9:40 am - 10:51 am CONCURRENT POSTER SESSION I: CANCER
Congressional C
(2 minute presentations, 2 minute discussions)
Moderators:
Richard K. Babayan
Arthur P. Mourtzinos
9:40 am VIEWING
9:55 am P1. Detection of metastatic disease in penile cancer patients with 18F-FDG PET/CT
Jill C. Buckley, MD, Leonard Zinman, MD
Lahey Clinic, Burlington, MA
9:59 am P2. Use of a Predictive Model for Discerning Clinically Significant Versus Indolent Prostate Cancer Prior to Prostate Biopsy
Stephen B. Williams, MD1, Meredith M. Regan, ScD2, John Wei, MD3, Michael Kearney, MD4, Williams C. DeWolf, MD4, Jeffrey Tang, MD5, Gerry Bueti, BS4 , Mark A. Rubin, MD5, Elizabeth Genega, MD4, Andrew Eyre, BS4, Martin G. Sanda, MD6
1Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 3University of Michigan, Ann Arbor, MI, 4Beth Israel Deaconess Medical Center, Boston, MA, 5Weill-Cornell Medical College, New York, NY, 6Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
10:03 am P3. Evaluating miRNA Expression Integrity in FFPE Samples with qRT-PCR byUsing Patient-matched Formalin-fixed and Fresh-frozen Tissues from Renal Cell Carcinoma (RCC) Patients
Van Le, BA1 David Juan, MA1, Derek Beaton, MA2, Benjamin Keenan, MA1, Yasmin Akbari, BA1, Joon Hee Lee, BA1,Tanmay Parekh, BA1, Travis Antes, PhD3, Louis Liou, MD, PhD1
1Boston University, Boston, MA, 2University of Massachusetts, Dartmouth, MA, 3System Biosciences, Mountain View, CA
10:07 am P4. Pulsed KTP Laser Coagulation of Submucosal Telangiectatic Vessels in Patients with Radiation Cystitis
Shahin Tabatabaei, MD, Sarah D. Psutka, MD, Mohammad M. Siddiqui, MD, W. Scott McDougal, MD
Massachusetts General Hospital, Boston, MA
10:11 am P5. Indication for Prostate Biopsy following Primary Total Surgical Cryoablation of the Prostate: Sensitivity of ASTRO Criteria
Martyn Vickers, Jr., MD, Elizabeth Tulip, PA-C
Penobscot Bay Medical Center, Rockport, ME
10:15 am P6. Diffusion-weighted MRI of the Prostate: Limits of Cancer Detection
Jennifer K. Yates, MD, Courtney Woodfield, MD, Gyan Pareek, MD, Joseph Renzulli, MD, George Haleblian, MD
Brown University, Providence, RI
10:19 am P7. Phase III ADT Trial Demonstrates Improvement In Gynecomastia In Men On
Toremifene 80 Mg Compared To Placebo
Robert Feldman, MD1, Michael Flanagan, MD1, York P. Moy, MD1, Anthony Kim, MD1, Shontelle Dodson, PharmD2, Domingo Rodriguez, MD2, Ronald A. Morton, MD2
1Connecticut Clinical Research Center, Middlebury, CT, 2GTx, Inc, Memphis, TN
10:23 am P8. Phase III Trial In Men On ADT Demonstrates A Reduction In Hot Flashes In
Men On Toremifene 80 Mg Compared To Placebo
Robert Feldman, MD1, Michael Flanagan, MD1, Anthony Kim, MD1, York P. Moy, MD1, Shontelle Dodson, PharmD2, Domingo Rodriguez, MD2, Ronald A. Morton, MD2
1Connecticut Clinical Research Center, Middlebury, CT, 2GTx, Inc, Memphis, TN
10:27 am P9. Assessing the Potential of the Htert Cell Line as a Model of Normal Bladder
Urothelium via Analysis of miRNA Expression
Yasmin Akbari, BA1, Derek Beaton, MA2, Benjamin Keenan, MA1, Van Le, BA1, Tanmay Parekh, BA1, Joon Hee Lee, BA1, Travis Antes, PhD3, Louis Liou, MD, PhD1
1Boston University, Boston, MA, 2University of Massachusetts, Dartmouth, MA, 3System Biosciences, Mountain View, CA,
10:31 am P10. Perioperative Complications of Robot-Assisted Laparoscopic Radical
Prostatectomy, an Unbiased Prospective Report
Michael S. Lasser, MD, Joseph F. Renzulli, MD, George F. Haleblian, MD, Harry C. Sax, MD, Gyan Pareek, MD
Brown University, Providence, RI
10:35 am P11. Choice of Nephron Sparing Technique correlates with change in GFR:
Percutaneous Radiofrequency Ablation (RFA) vs. Open and Laparoscopic Partial Nephrectomy
Ali K. Daha, MBBS., Audley L. Osbourne, MD, Christopher J. Cutie, MD, Debra A. Gervais, MD, Douglas M. Dahl, MD, Adam S. Feldman, MD
Massachusetts General Hospital, Boston, MA,
10:39 am P12. SRD5a2 Gene Polymorphisms And Risk For Prostate Cancer
Jun Li, MD, PhD, Ralph J. Coates, PhD, Marta Gwinn, MD, MPH, Khoury J. Muin, MD, PhD
CDC Atlanta, GA
10:43 am P13. Trends in the Care of Radical Prostatectomy in the United States from 2003-2006
Aaron C. Weinberg, BS1, Jeremy Shelton, MD1, Nathanael D. Hevelone, MPH2, Stuart Lipsitz, PHD3, Jim C. Hu, MD, MPH1.
1Division of Urologic Surgery Brigham and Women’s Hospital, Boston, MA, USA, 2Division of Vascular Surgery, UCSF Medical Center, San Francisco, CA, USA, 3Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, USA.
10:47 am P14. Use of Narcotic medications after surgical treatment for organ confined prostate cancer
Aaron C. Weinberg, BS1, Xiangmei Gu, MS2, Stuart Lipsitz, PhD2, Marcos P. Freire, MD, Lei Yin, MD1, Sergey K. Kravichick, MD2, 1Jim C. Hu, MD, MPH1
1Division of Urologic Surgery Brigham and Women’s Hospital, Boston, MA, 2Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA
10:50 am - 11:20 am COFFEE BREAK, VISIT EXHIBITS
Grand Ballroom South/Central
11:20 am - 11:50 am Joel Blau
Mediqus Asset Advisors
11:50 am - 12:20 am INVITED GUEST SPEAKER
Grand Ballroom North
I'm Not A Pilot
Louis R. Kavoussi, MD
North Shore University Hospital, Manhasset, NY
12:20 am - 1:20 pm SCIENTIFIC SESSION V: STONES
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Louis R. Kavoussi
David S. Wang
12:20 am 27. Lower Pole Fluoroscopic-Guided Percutaneous Renal Access: Which Calyx Is Posterior?
Brian H. Eisner, MD1, Jordan Cloyd, BA2, Marshall L. Stoller, MD2
1Massachusetts General Hospital, Boston, MA, 2University of California, San Francisco, San Francisco, CA
12:30 am 28. Staged Percutaneous Nephrolithotomy Results in Lower Rates of Bacteremia/Sepsis and Lower Hospitalization Cost
Jairam R. Eswara, MD, Dianne Sacco, MD
Massachusetts General Hospital, Boston, MA
12:40 pm 29. Impact of Urinary Sodium on the Urinary Risk Factors for Calcium Oxalate
Brian H. Eisner, MD1, Michael L. Eisenberg, MD2, Marshall L. Stoller, MD2
1Massachusetts General Hospital, Boston, MA, 2University of California, San Francisco, San Francisco, CA
12:50 pm 30. Citrate, Malate, and Akali Concentrations in Commonly Consumed Diet Sodas: Implications for Urinary Stone Patients
Brian H. Eisner, MD1, John R. Asplin, MD2, Marshall L. Stoller, MD3
1Massachusetts General Hospital, Boston, MA, 2Litholink Corporation, Chicago, IL, 3 University of California, San Francisco, San Francisco, CA
1:00 pm 31. Changing Stone Composition in Recurrent Stone Formers
Kashif Alvi, MD, Mohummad M. Siddiqui, MD, Sharif-Tabrizi Ahmad, MD Stephen P. Dretler, MD, Dianne Sacco, MD
Massachusetts General Hospital, Boston, MA
1:10 pm 32. Neuromuscular Disorders Predisopose Patients to Urosepsis after PCNL: Efficacy of Staged PCNL
Jairam R. Eswara, MD, Dianne Sacco, MD
Massachusetts General Hospital, Boston, MA
1:20 pm - 2:30 pm Lunch Symposium
Meeting Rooms 8 & 9
Androgen deprivation therapy induced estrogen deficiency side effects
Supported by GTx, Inc.
2:30 pm - 3:40 pm CONCURRENT SCIENTIFIC SESSION VI: ERECTILE DYSFUNCTION/INCONTINENCE
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Nelson E. Bennett Jr.
Anurag K. Das
2:30 pm 33. Initial Experience with the AdVance Male Urethral Sling
Robert C. Eyre, MD
Beth Israel Deaconess Medical Center, Boston, MA
2:40 pm 34. Outcome and Cost Comparison between Open and Robotic Ileovesicostomy for the Neurogenic Bladder Patient
Alex J. Vanni, MD1, Kevin Bennett, BA1, Linda Ng, MD2, John T. Stoffel, MD1
1Lahey Clinic, Burlington, MA, 2Boston University, Boston, MA
2:50 pm 35. Intramuscular Detrusor Injection of Botulinum Toxin Type A as a Therapeutic Option for Bladder Preservation in Patients With Severe Neurogenic Detrusor Overactivity
David Gordon, MD, Todd Lehrfeld, MD, Joseph Serio, RN, Mary Beck-Grimm, PA-C, Tao Nguyen, MD
Chesapeake Urology Associates, Owings Mills, MD
3:00 pm 36. Transanal Transrectal Repair Of Rectourethral Fistula Utilizing A DartosFlap Interposition
Gjanje Smith, MD1, Shlomo Raz, MD2, Arthur Mourtzinos, MD1
1Lahey Clinic Medical Center, Burlington, MA, 2UCLA Medical Center, Los Angeles, CA
3:10 pm 37.+ Severe, Disabling, And/Or Chronic Penile Pain Associated With Peyronie's Disease: Management With Non-Intralesional Administration Of Steroids
Rian J. Dickstein, MD, Jayant Uberoi, MD, Ricardo Munarriz, MD
Boston Medical Center, Boston, MA
3:20 pm 38. Is Intracavernosal Injection Therapy a Dinosaur? Long-Term Efficacy and Safety
Kevin Asher, MD, Daniel Martinez, MD, Terry Payton, RN, Ricardo Munarriz, MD
Boston University, Boston, MA
3:30 pm 39.+ Pharmacotherapy for Erectile Dysfunction Following Treatment for Prostate Cancer in the United States: Retention and Cost
Michaella M. Prasad, MD1, Sandip M. Prasad, MD2, M.Phil1, Aaron C. Weinberg, BA2, Xiangmei Gu, MS3, Nathanael D. Hevelone, MPH3 , Stuart R. Lipsitz, ScD3, Ganesh S. Palapattu, MD4, Jim C. Hu, MD, MPH5
1Harvard Longwood Program in Urology, Boston, MA, 2Division of Urologic Surgery, Brigham and Women’s Hospital, Boston, MA, 3Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, MA, 4Department of Urology, University of Rochester Medical Center, Rochester, NY, 5Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA
2:30 pm - 3:42 pm CONCURRENT POSTER SESSION II: BASIC SCIENCE
Congressional C
(2 minute presentations, 2 minute discussions)
Moderators:
Aria F. Olumi
John A. Taylor, III
2:30 pm VIEWING
2:45 pm P15. A Genetic Animal Model for Bladder Dysfunction Associated with Type 2 Diabetes
Zongwei Wang, MD, PhD1, Maryrose Sullivan, PhD2, Zhiyong Cheng, PhD3, Morris White, PhD3, Pablo Gomery, MD1, Aria F. Olumi, MD1
1Massachusetts General Hospital, Boston, MA, 2West Roxbury VA, Boston, MA, 3Children's Hospital, Boston, MA
2:49 pm P16. MicroRNA Expression Profile Predictive of High Grade Non-Invasive Urothelial Cancer Progression
Sara M. Lenherr, MD, Sheaumei Tsai, MD, Cara B. Cimmino, MD, Kimberly M. Rieger-Christ, PhD, John A. Libertino, MD, Ian C. Summerhayes, PhD
Lahey Clinic Medical Center, Burlington, MA
2:53 pm P17. F-box protein 10, a Novel Anti-Apoptotic Protein, Represses c-Fos and Regulates TRAIL-induced Apoptosis
Rongbin Ge, MD. PhD, Zongwei Wang, MD, PhD, Aria F. Olumi, MD
Massachusetts General Hospital, Boston, MA
2:57 pm P18. Resistance to Finasteride Therapy in Prostate Epithelial Cells
Yinong Niu, MD, Christian R. Diaz, MD, Wenhua Li, MD, Zongwei Wang, PhD, Aria F. Olumi, M.D
Massachusetts General Hospital, Boston, MA
3:01 pm P19. Human Alpha-synuclein Transgenic Mice: A Novel Animal Model of Lower Urinary Tract Dysfunction in Parkinson's Disease
Richard T. Kershen, MD, Margaret Vizzard, PhD, Robert Hamill, MD
University of Vermont, Burlington, VT
3:05 pm P20. Induction of Prostate Specific Antigen Gene Expression in Co-cultured Normal Human Bone Marrow Cells
Joseph F. Renzulli II, MD, Gerri Dooner, MA, Anthony Mega, MD, Lisa Goldstein, MD, Gerald Colvin, DO, Peter Quesenberry, MD
Brown University, Providence, RI
3:09 pm P21. MicroRNA Profiling Can Distinguish Normal From Neoplastic Urothelium
Benjamin Keenan, MA1, Derek Beaton, MA2, Van Le, BA1, Yasmin Akbari, BA1, Joon Hee Lee, BA1, Tanmay Parekh, BA1, Travis Antes, PhD3, Louis Liou, MD, PhD1
1Boston University, Boston, MA, 2University of Massachusetts, Dartmouth, MA, 3System Biosciences, Mountain View, CA
3:14 pm P22. Role of PKD1 in Production of MMP-2, MMP-9 and E-Cadherin Shedding In Prostate Cancer Cells
Helal U. Biswas, PhD, Chaunyou Zhang, PhD, Cheng Du, PhD, K. C. Balaji, MD
University of Massachusetts Medical School, Worcester, MA
3:18 pm P23. Expression Of The Genomic Organizer Special AT-Rich Sequence Binding Protein-1 (SATB1) In Bladder Cancer Cell Lines
Maria A. Voznesensky, Shilpa Choudhary, Olga S. Voznesensky, Carol Pilbeam, PhD, MD, John A. Taylor, III, MD
University of Connecticut, Farmington, CT
3:22 pm P24. Differential Subcellular Localization of Threonine-120 Phosphorylated – catenin in Human Prostate Cancer is a Novel Functional Marker
Cheng Du, PhD , Chuanyou Zhang, PhD, K.C. Balaji, MD
Univesity of Massachusetts Medical Center, Worcester, MA
3:26 pm P25. Notch-1 staining intensity and survival in patients with renal cell carcinoma
Shaun E. L. Wason, MD1, Renee Robinson, MD1, Tom Schwaab, MD2, Maudine Waterman, HT1, Peter L. Steinberg, MD1, John D. Seigne, MD1, Alan Schned, MD1, Marc Ernstoff, MD2
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Immunology and Cancer Immunotherapy Research Program, Lebanon, NH
3:30 pm P26. Utilization Of Silk As A Novel Biomaterial In Bladder Augmentation
Glenn M. Cannon, Jr., MD, Edward M. Gong, MD, Joshua R. Mauney, PhD, Madavi Oliver, P.D, Patricia S. Dunning, RT, Richard N. Yu, MD, PhD, Roslyn M. Adam, PhD, Carlos R. Estrada, MD
Children's Hospital, Boston, MA
3:34 pm P27. Defining The Effects of Hypofractionated Radioablation of Renal Cell Carcinoma in a Mouse Model
Anna L. Dowdle, BS, Rupal Bhatt, MD, Elizabeth Genega, MD, Salvatore LaRosa, MS, Irving Kaplan, MD, Xing-Qi Lu, PhD, Nahum Goldberg, MD, Liang Zhang, MD, Xiaoen Wang, MD, Ivan Pedrosa, MD, David Alsop, PhD, Andrew A. Wagner, MD
Beth Israel Deaconess Medical Center, Boston, MA
3:38 pm P28. Age Increases The Expression Of Inflammatory Genes In A Mouse Model Of Bladder Cancer
John A. Taylor, III, MD, Shilpa Choudhary, George A. Kuchel, MD, Benjamin Ristau, MD, Olga S. Voznesensky, Poornima Hegde, MD, Carol Pilbeam, PhD, MD
University of Connecticut, Farmington, CT
3:40 pm - 4:10 pm COFFEE BREAK, VISIT EXHIBITS
Grand Ballroom South/Central
4:10 pm - 5:10 pm UROLOGY ROUNDS-TOUGH CASES
Meeting Rooms 12 - 13
4:10 pm - 5:10 pm SCIENTIFIC SESSION VII: PEDIATRICS
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Anthony A. Caldamone
Joseph G. Borer
4:10 pm 40. Transcatheter Embolization of Varicocele Using Sotradecol Foam
Eric Reiner, DO, Melih Arici, MD, Jonathan Kirsch, MD, Hamid Mojibian, MD, Jeffrey Pollak, MD Katharine Henderson, MS, Robert White Jr., MD, Robert Weiss, MD
Yale University School of Medicine, New Haven, CT
4:20 pm 41. Economic and Radiation Costs of Screening Regimens for Vesico-Ureteral Reflux: a Decision Analysis
Jonathan C. Routh, MD1, Frederick D. Grant, MD1, Caleb P. Nelson, MD1, MPH, Fredrich H. Fahey, DSc2, A. Ted Treves, MD2 Richard S. Lee, MD1
1Children's Hospital Boston, Boston, MA, 2 Division of Nuclear Medicine, Children’s Hospital Boston, Boston, MA
4:30 pm 42. Primary Mini-Cystoscopic Ablation of Posterior Urethral Valve Mandates Second Look Cystoscopic Follow-Up
Andrew S. Nisbet, MD1, Fernando A. Ferrer, Jr., MD1,2, Katherine W. Herbst, BA2, Christina Kim, MD1,2, John H. Makari, MD1,2
1University of Connecticut, Farmington, CT, 2Connecticut Children's Medical Center, Hartford, CT
4:40 pm 43. Transurethral Incision for Ureterocele
Dacia Di Renzo, MD1, Pamela I. Ellsworth, MD2, Pierluigi Lelli Chiesa, MD1, Anthony A. Caldamone, MD2
1Pediatric Surgery Department “D’Annunzio University, Chieti-Pescara, Italy, 2Rhode Island Hospital, Providence, RI
4:50 pm 44. Robotic Assisted vs. Pure Laparoscopic Surgery in Pediatric Urology
Daniel B. Herz, MD, Paul A. Merguerian, MD
Children's Hospital at Dartmouth / Dartmouth-Hitchcock Medical Center, Lebanon, NH
5:00 pm 45. Open Ureteral Reimplantation Does Not Affect the Quality of Life in Children with Vesicoureteral Reflux: Assessment of Health-Related Quality-of-Life Using the Pediatric Quality of Life Inventory
David F. Yao, MD, Frank J. Penna, MD, Brian J. Minnillo, MD, Aaron C. Weinberg, BS, Hiep T. Nguyen, MD
Children's Hospital Boston, Boston, MA,
5:10 pm ADJOURN
6:30 pm - 8:30 pm ATTENDEE RECEPTION
Newseum
SATURDAY, SEPTEMBER 26, 2009
7:00 am - 7:45 am BUSINESS MEETING
Grand Ballroom North
7:00 am - 10:30 am Exhibit Hall
Grand Ballroom South/Central
7:00 am - 8:00 am CONTINENTAL BREAKFAST, VISIT EXHIBITS
Grand Ballroom South/Central
8:00 am - 9:10 am CONCURRENT SCIENTIFIC SESSION VIII: ONCOLOGY
Grand Ballroom North
(7 minute presentations, 3 minute discussions)
Moderators:
Arie Belldegrun
Michael O’Donnell
8:00 am 46. The Use Of KTP Laser For Ablation Of Small, Low Grade Transitional Cell
Carcinoma Of Bladder In Outpatient, Office Setting
Mohammad M. Siddiqui, MD, Joseph A. Grocela, MD, W. Scott McDougal, MD, Sarah D. Psutka, MD, Shahin Tabatabaei, MD Massachusetts General Hospital, Boston, MA
8:10 am 47. Durability of Response: The Achilles Heel of Salvage Combination Immunotherapy with Intravesical Bacillus Calmette Guerin and Interferon-Alpha 2B
Sandip M. Prasad, MD, M. Phil. , Stephen J. Eyre, MD, William V. Shappley, III, MD, Kevin R. Loughlin, MD, MBA
Harvard-Longwood Program in Urology, Boston, MA
8:20 am 48. Vaccination of Patients with Metastatic Renal Carcinoma with Dendritic Cell/Tumor Fusions Following Debulking Nephrectomy
Jacalyn Rosenblatt, MD1, Andrew Wagner, MD1, Michael Atkins, MD1, David McDermott, MD1, Cho Daniel, MD1, Baldev Vasir, PhD2, Zekui Wu, MD2, Lynne Uhl, MD1, Somaya Poorvi, BA1, Heidi Mills, BA1, Brett Glotzbecker, MD1, Donna Fitzgerald, PA1, Karen Lowe, RN1, Dilani Dombogado, BA1, Evan Barnathan, BA1, Kerry Wellenstein, BA1, Martin Sanda, MD1, William DeWolf, MD1, Donald Kufe, MD2, David Avigan, MD1
1Beth Israel Deaconess Medical Center, Boston, MA, 2Dana Farber Cancer Institute, Boston, MA
8:30 am 49. Hexaminolevulinate (Hal) Fluorescence Cystoscopy Vs White Light Cystoscopy (Wl) Comparing Detection Of Ta And T1 Tcc Of Bladder And 9 Months Recurrence - Results Of A Multi-Center Trial
Richard K. Babayan, MD1, Lance Mynderse, MD2, Mark Soloway, MD3, Unyime Nseyo, MD4, Seth Lerner, MD5, Ed Messing, MD6, H. Barton Grossman, MD7, H. Barton Grossman, MD7
1Boston University, Boston, MA, 2Mayo Clinic, Rochester, MN, 3University of Miami, Miami, FL, 3VAMC, Gainesville, FL, 5Baylor College of Medicine, Houston, TX, 6University of Rochester, Rochester, NY, 7MD Anderson Cancer Center, Houston, TX
8:40 am 50. A Retrospective Review of Patients Evaluated for Small Solid Renal Masses During a Two Year Period
Brian Kowal, MD, William Bihrle, III, MD, Andrew Forauer, MD, John D. Seigne, MB
Dartmouth-Hitchcock Medical Center, Lebanon, NH
8:50 am 51. Open Versus Robot-Assisted Radical Cystectomy: Comparison Of Early Outcomes and Cost
Sheaumei Tsai, MD, Arthur Mourtzinos, MD, Andrea Sorcini, MD, Karim Hamawy, MD, John A. Libertino, MD, David Canes, MD, Ali Moinzadeh, MD
Lahey Clinic, Boston, MA
9:00 am 52. The Use of KTP Laser Tumor Ablation for Management of Extensive Transitional Cell Carcinoma of Bladder (Initial Results)
Shahin Tabatabaei, MD, Sarah D. Psutka, MD, Mohammad M. Siddiqui, MD
Massachusetts General Hospital, Boston, MA
8:00 am - 9:11 am CONCURRENT POSTER SESSION III: COMMUNITY UROLOGY
Congressional C
(2 minute presentations, 2 minute discussions)
Moderators:
Timothy B. Hopkins
Jeffrey A. Ranta
8:00 am VIEWING
8:15 am P29. Comparison of Laparoscopic and Open Partial Nephrectomy. A Retrospective Review At The Massachusetts General Hospital
Audley L. Osbourne, MD, Ali K. Daha, MD, Christopher J. Cutie, MD, Dahl M. Dahl, MD, Adam S. Feldman, MD
Massachusetts General Hospital, Boston, MA
8:19 am P30. Silodosin Promotes Rapid Improvement of Irritative and Obstructive Urinary Symptoms in Men With Benign Prostatic Hyperplasia
Marc C. Gittelman, MD1, Lawrence Hill, RPh, PhD2, Weining Volinn, MS2, Gary Hoel, PhD2
1South Florida Medical Research, Aventura, FL, 2Watson Laboratories, Inc., Salt Lake City, UT
8:23 am P31. Early Experience with the AdVanceTM Male Sling
Michael Poch, MD, Simone Thavaseelan, M.D., Lanna Cheuck, M.D., Kennon Miller, M.D., Joseph Renzulli II, M.D
Brown University, Providence, RI
8:27 am P32. Pre-Chemotherapy Sperm Procurement In Teenagers: Analysis Of Outcomes And Predictors Of Sperm Retrieval
Nelson Bennett, Jr., MD1, John Mulhall, MD2
1Lahey Clinic Medical Center, Burlington, MA, 2Memorial Sloan-Kettering Cancer Center, New York, NY
8:31 am P33. 5-Year Prospective Results of DMSA Renal Imaging in Children with Febrile Urinary Tract Infection: The Top-Down Approach
Daniel B. Herz, MD, Paul A. Merguerian, MD, Leslie McQuiston, MD, Mary Gheen, ARNP, Christine Danielson, ARNP
Children's Hospital at Dartmouth / Dartmouth-Hitchcock Medical Center, Lebanon, NH
8:35 am P34. Urodynamic and Symptomatic Improvement After Treatment With Silodosin in Men With Symptoms Secondary to Benign Prostatic Hyperplasia: Relationship Between Efficacy and Retrograde Ejaculation
Klaus G. Roehrborn, MD1, Herbert Lepor, MD2, Steven A. Kaplan, MD3, Weining Volinn, MS4, Lawrence A. Hill, RPh, PhD4
1UT Southwestern Medical Center, Dallas, TX, 2NYU School of Medicine, New York, NY, 3Weill Medical College, Cornell University, New York, NY, 4Watson Laboratories, Inc., Salt Lake City, UT
8:39 am P35. Practice Patterns Of Methodologies For Treatment Of Renal And Ureteral Stones
Mohummad M. Siddiqui, MD1, Stephen D. Adlard, BS1, Robin O. Cleveland, PhD2, Stephen P. Dretler, MD1, Dianne E. Sacco, MD1
1Massachusetts General Hospital, Boston, MA, 2Boston University, Boston, MA
8:43 am P36. Long-Term Injection Therapy Outcomes: Treatment Efficacy and Patient Satisfaction
Kevin Asher, MD, Daniel Martinez, MD, Ricardo Munarriz, MD
Boston University, Boston, MA
8:47 am P37. Factors Influencing The Pursuit Of Fellowship Training By Women Urologists
Brooke A. Harnisch, MD1, Kelly L. Stolzmann, MS2, Lori B. Lerner, MD2
1Boston University, Boston, MA, 2VA Boston Healthcare System, Boston, MA
8:51 am P38. Eighteen-Month Results of a Three-Year Trial of Nonsurgical Transurethral Collagen Denaturation for Stress Urinary Incontinence
Denise Elser, MD1, Gretchen Mitchell, MD2, John Miklos, MD2, Kevin Nickell, MD3, Kevin Cline, MD4, Harvey Winkler, MD5, W. Glen Wells, MD6
1Illinois Urogynecology, LTD, Oaklawn, IL, 2Atlanta Urogynecology Associates, Alpharetta, GA, 3Houston Metro Urology, Sugarland, TX, 4Regional Urology, LLC, Shreveport, LA, 5North Shore Women’s Health, Great Neck, NY, 6Alabama Research Center, LLC., Birmingham, AL
8:55 am P39. Validation Of The Overactive Bladder Symptom Score (Oabss) In Spanish
Aaron C. Weinberg, BA1, Gary H. Brandeis, MD1, Jeffery P. Weiss, MD2, John Bruyere, BS1, Mathew Rutman, MD3, Blaivas G. Jerry, MD4

1Boston Medical Center, Boston, MA, 2Down State Medical Center, Brooklyn, NY, 3Columbia Medical Center, New York, NY, 4Cornell Medical Center, New York, NY
8:59 am P40. Is Having a VCUG that Horrible: Assessment of Parental Satisfaction in Children Undergoing Voiding Cystourethrography
Brian J. Minnillo, MD, Andres D Silva, MD, Frank J. Penna, MD, Jeanne S. Chow, MD, Angela M. Franceschi, Med, CCLS, Sonja Ziniel, PhD, Natascha Sandy, BS, Hiep T. Nguyen, MD
Children's Hospital Boston, Boston, MA
9:03 am P41. Differences In 24-Hour Urine Composition Between White And Asian/Pacific Islander Stone-Formers
Brian H. Eisner, MD1, Sima P. Porten, MD2, Seth Bechis, BA2, Marshall L. Stoller, MD2
1Massachusetts General Hospital, Boston, MA, 2University of California, San Francisco, San Francisco, CA
9:07 am P42. Laparoscopic Versus Robotic Assisted Partial Nephrectomy: One Fellowship-Trained Surgeon's Experience
Jessica DeLong, MD1, Oleg Shapiro, MD2, Ali Moinzadeh, MD1
1The Lahey Clinic, Burlington, MA, 2State University Of New York, Syracuse, NY
9:11 am - 10:00 am VIDEO SESSION
Grand Ballroom North
Moderators:
Jim C. Hu
Joseph R. Wagner
  V1. Robotic-Assisted Laparoscopic Partial Nephrectomy: A Hybrid Technique
Anne M. Suskind, MD1, Ryan C. Jackson2, Stuart S. Kesler, MD2, Steven J. Shichman, MD2
1University of Connecticut, Farmington, CT, 2Hartford Hospital, Hartford, CT
  V2. Consistent Bladder Neck Sparing During Robotic Assisted Laparoscopic Radical Prostatectomy
Lei Yin, MD, Aaron C. Weinberg, PHD, Marcos P. Freire, PHD, Sergey K. Kravichick,MD, Xiangmei Gu, PHD, Stuart R. Lipsitz, PHD, Jim C. Hu, MD PHD.
Brigham & Women's Hospital, Boston, MA
  V3. Management of a Large Median Lobe during Robot Assisted Radical Prostatectomy
Rian J. Dickstein, MD, Aaron C. Weinberg, BA, David S. Wang, MD, Richard K. Babayan, MD
Boston Medical Center, Boston, MA
  V4. Skeletonization of DVC followed by ligature with a single stitch during RALRP
Lei Yin, MD, Aaron C. Weinberg, PHD, Marcos P. Freire, PhD, Sergey K. Kravichick, MD, Xiangmei Gu, PhD1, Stuart R. Lipsitz, PHD, Jim C. Hu, MD, PhD
Brigham and Women Hospital, Boston, MA
10:00 am - 10:30 am COFFEE BREAK, VISIT EXHIBITS
Grand Ballroom South/Central
10:30 am - 11:00 am INVITED GUEST SPEAKER
Grand Ballroom North
New Developments in the Management of Non-Muscle-Invasive Bladder Cancer
Michael O’Donnell, MD
University of Iowa, Iowa City, IA
11:00 am - 12:00 pm LEADBETTER LECTURE
Grand Ballroom North
Personalized Kidney Cancer Therapy: The Future is Here
Professor Arie Belldegrun
UCLA Urology, Los Angeles, CA
12:00 pm - 12:30 pm PRESIDENTIAL ADDRESS
Grand Ballroom North
Massachusetts Universal Healthcare: Lessons Learned
Kevin R. Loughlin, MD
Brigham & Women's Hospital, Boston, MA
12:30 pm ADJOURN
7:00 pm –11:00 pm PRESIDENT’S RECEPTION & DINNER
International Spy Museum: Zola
(Business Casual)
SUNDAY, SEPTEMBER 27, 2009
7:00 am - 12:00 pm ULTRASOUND HANDS-ON COURSE (25 MAX)